Company intelligence / Profile preview

Sanolla

Nesher, Israelsanolla.com ↗
Ownership
Private
Employees
~20
Development stage
Commercial
01

Overview

Sanolla has developed the world’s first AI-ready infrasound stethoscope ("VoqX") that captures low-frequency body sounds not audible to humans. The device received FDA clearance and Israeli Health Ministry approval. Their proprietary AI algorithms enable advanced classification of cardiopulmonary diseases such as COPD, pneumonia, asthma, and cardiac conditions. The company also offers the PyXy home monitoring device for chronic disease management. Clinical results show promise for improved non-invasive diagnosis and early exacerbation detection; however, detailed published clinical trial data are not available yet.

Therapeutic areas
PulmonologyCardiovascularInfectious Diseases
Modalities
DeviceArtificial intelligence platform (for disease classification)Non-pharmacological therapy (diagnostic/monitoring devices)
Industry
Physiological Monitoring
02

Partnerships

NextLeap VenturesPlug and Play JapanEuropean Union Horizon2020 programmeIsrael Innovation Authority

Beyond the preview

Go deeper on Sanolla.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanolla.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call